Published on October 25, 2019
Patient Power host and advocate Carol Preston sits down with leading chronic lymphocytic leukemia (CLL) expert Dr. Philip Thompson to share important takeaways from the International Workshop on CLL (iwCLL) 2019 in Edinburgh, Scotland. Watch as Dr. Thompson discusses novel CLL combination therapies, a new drug approval underway and updates on CAR-T cell therapy.
To learn more about the meeting visit www.iwcll2019.org.
This program is sponsored by CLL Global Research Foundation. This organization has no editorial control. It is produced by Patient Power and Patient Power is solely responsible for program content.
Please remember the opinions expressed on Patient Power are not necessarily the views of our sponsors, contributors, partners or Patient Power. Our discussions are not a substitute for seeking medical advice or care from your own doctor. That’s how you’ll get care that’s most appropriate for you.
I consider myself a pretty well educated CLL patient but there was much presented today that was new to me, and much more that expanded upon what I already knew or filled in missing bits of information.